IPD Stock Overview
A medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
ImpediMed Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.074 |
52 Week High | AU$0.24 |
52 Week Low | AU$0.074 |
Beta | 2.93 |
1 Month Change | -8.64% |
3 Month Change | -29.52% |
1 Year Change | -52.26% |
3 Year Change | -35.65% |
5 Year Change | -45.19% |
Change since IPO | -91.29% |
Recent News & Updates
Recent updates
ImpediMed (ASX:IPD) Is In A Good Position To Deliver On Growth Plans
Mar 05Companies Like ImpediMed (ASX:IPD) Are In A Position To Invest In Growth
Nov 23Is ImpediMed (ASX:IPD) In A Good Position To Deliver On Growth Plans?
Jul 11We Think ImpediMed (ASX:IPD) Needs To Drive Business Growth Carefully
Mar 27Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation
Sep 28We're Not Worried About ImpediMed's (ASX:IPD) Cash Burn
Jun 10A Look At The Fair Value Of ImpediMed Limited (ASX:IPD)
Feb 01We Think ImpediMed (ASX:IPD) Can Afford To Drive Business Growth
Aug 25Here's Why We're Not Too Worried About ImpediMed's (ASX:IPD) Cash Burn Situation
Apr 06Analysts Expect Breakeven For ImpediMed Limited (ASX:IPD) Before Long
Feb 12ImpediMed's (ASX:IPD) Stock Price Has Reduced 88% In The Past Five Years
Jan 08How Does ImpediMed's (ASX:IPD) CEO Salary Compare to Peers?
Nov 25Shareholder Returns
IPD | AU Medical Equipment | AU Market | |
---|---|---|---|
7D | -6.3% | 0.1% | -0.5% |
1Y | -52.3% | 17.6% | 9.0% |
Return vs Industry: IPD underperformed the Australian Medical Equipment industry which returned 17.6% over the past year.
Return vs Market: IPD underperformed the Australian Market which returned 9% over the past year.
Price Volatility
IPD volatility | |
---|---|
IPD Average Weekly Movement | 9.2% |
Medical Equipment Industry Average Movement | 9.3% |
Market Average Movement | 8.7% |
10% most volatile stocks in AU Market | 16.8% |
10% least volatile stocks in AU Market | 3.3% |
Stable Share Price: IPD's share price has been volatile over the past 3 months.
Volatility Over Time: IPD's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 76 | Parmjot Bains | www.impedimed.com |
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics.
ImpediMed Limited Fundamentals Summary
IPD fundamental statistics | |
---|---|
Market cap | AU$149.71m |
Earnings (TTM) | -AU$19.50m |
Revenue (TTM) | AU$10.47m |
14.3x
P/S Ratio-7.7x
P/E RatioIs IPD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IPD income statement (TTM) | |
---|---|
Revenue | AU$10.47m |
Cost of Revenue | AU$1.37m |
Gross Profit | AU$9.11m |
Other Expenses | AU$28.60m |
Earnings | -AU$19.50m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0096 |
Gross Margin | 86.95% |
Net Profit Margin | -186.16% |
Debt/Equity Ratio | 0% |
How did IPD perform over the long term?
See historical performance and comparison